Copy Link Print Information

Siplizumab

(Synonyms: MEDI-507; TCD601)
Avis client

Based on 1 Customer Validation

Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.83%
  • CAS No.: 288392-69-8
  • Masse moléculaire:146.25 kDa
  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Siplizumab
  • Experimental Validation Results for Siplizumab
  • Experimental Validation Results for Siplizumab
  • Siplizumab Chemical Structure
    Siplizumab Chemical Structure
CAS No.: 288392-69-8
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Siplizumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG1 kappa

  • 1/16

    Immobilized Human CD2 Protein (ECD, His Tag) can bind Siplizumab. The EC50 for this effect is 1.441 ng/mL.

  • 1/16

    Loaded Siplizumab on AHC2 biosensor, can bind CD2 Protein, Human (HEK293, His, HY-P7882) with an affinity constant of 3.775E-09 M as determined in BLI assay.

  • Siplizumab Chemical Structure
    1/16
  • Siplizumab
  • Immobilized Human CD2 Protein (ECD, His Tag) can bind Siplizumab. The EC50 for this effect is 1.441 ng/mL.
  • Loaded Siplizumab on AHC2 biosensor, can bind CD2 Protein, Human (HEK293, His, HY-P7882) with an affinity constant of 3.775E-09 M as determined in BLI assay.